205313-82-2

Upstream product

• 2219-82-1 2-tert-Butyl-6-methylphenol 
• 10396-84-6 2-tert-butyl-4-nitro-6-methylphenol 
• 108-24-7 acetic anhydride 

Downstream Products

• 205313-78-6 (2-pyridylmethyl)(2-hydroxy-3-tert-butyl-5-methoxybenzyl)(2-hydroxy-3-tert-butyl-5-nitrobenzyl)amine 
• 205313-84-4 Acetic acid 2-tert-butyl-4-nitro-6-{[(pyridin-2-ylmethyl)-amino]-methyl}-phenyl ester 
• 205313-85-5 2-tert-Butyl-4-nitro-6-{[(pyridin-2-ylmethyl)-amino]-methyl}-phenol 

Relevant academic research and scientific papers

Edaravone analogue as well as preparation method and application thereof

Edaravone analogue, preparation method thereof and application, compound according to the following structural formula: In-flight, R1 And R2 The compounds of the present invention are methyl, methoxy, ethyl, isopropyl, tert-butyl or sec-butyl . with GABAA receptor enhancing activity and radical scavenger activity, having neuroprotective action, and compounds of the present invention can be used as a stroke prevention and treatment drug.

A Class of Ligands Designed as Model for Apogalactose Oxidase

Seven tripodal tetradentate ligands bearing one pyridine and two diversely substituted phenolic arms, designed as models for apogalactose oxidase, have been synthesized.Electrochemical one-electron oxidation of acetonitrile solutions of the ligands led to